In cancer therapy, CSCs have been intensely researched in recent years, and CSC markers, such as CD44 and CD133, have been shown to be enhanced in three-dimensional spheroid cultures than in two-dimensional monolayer cultures, since these cultures mimic the in vivo microenvironment34–37. Here, CD44 is linked to cancer.